Thymosin Alpha-1 Dosage Guide

Complete guide to Thymosin Alpha-1 dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Clinical dosing typically ranges from 1.6mg to 6.4mg administered subcutaneously 2-3 times weekly. Research protocols may vary.

Administration Method

Subcutaneous injection. Often used in cycles or as part of comprehensive immune support protocols.

Side Effects to Monitor

Generally well-tolerated. Rare side effects include injection site reactions, mild flu-like symptoms, and temporary fatigue.

Safety Considerations & Risks

Should be used cautiously in autoimmune conditions. May interact with immunosuppressive medications. Consult healthcare provider before use.